
Orlando Magic · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 21.5 | 9.3 | 2.3 | 3.7 | 15.3 | 1.3 | 0.3 | 1.7 | 3.0 | 5.7 |
| 52.9% |
| 0.7 |
| 2.7 |
| 25.0% |
| 1.3 |
| 1.7 |
| 80.0% |
| Last 5 | 5 | 26.2 | 16.0 | 3.2 | 3.2 | 22.4 | 1.4 | 1.0 | 1.6 | 3.8 | 7.6 | 50.0% | 1.8 | 4.6 | 39.1% | 3.0 | 4.2 | 71.4% |
| Last 10 | 10 | 29.3 | 18.2 | 3.4 | 3.6 | 25.2 | 1.1 | 0.6 | 2.1 | 3.7 | 7.4 | 50.0% | 2.1 | 5.0 | 42.0% | 4.5 | 5.5 | 81.8% |
| Last 20 | 20 | 31.8 | 19.1 | 4.0 | 4.2 | 27.2 | 1.4 | 0.4 | 1.9 | 4.4 | 8.6 | 51.5% | 2.0 | 5.0 | 40.4% | 4.3 | 4.9 | 87.8% |
| Season | 82 | 33.6 | 20.1 | 4.1 | 4.1 | 28.3 | 1.0 | 0.5 | 2.0 | 5.1 | 9.5 | 53.5% | 2.0 | 5.2 | 39.1% | 3.8 | 4.2 | 90.8% |
low rim finishing off the ball, low contested shots per minute, low offensive rebounding, high on-ball creation
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | ORL @ BOS | L | 17.6 | 8 | 2 | 1 | 1 | 1 | 0 | 3 | 8 | 37.5% | 1 | 4 | 25.0% | 1 | 2 | 50.0% | 9.0 |
| 2026-04-10 | ORL @ CHI | W | 17.3 | 2 | 1 | 4 | 2 | 0 | 1 | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 0 | 0 | 0.0% | 4.0 |
| 2026-04-08 | ORL vs. MIN | W | 29.7 | 18 | 4 | 6 | 1 | 0 | 4 | 7 | 13 | 53.8% | 1 | 4 | 25.0% | 3 | 3 | 100.0% | 22.0 |
| 2026-04-06 | ORL vs. DET | W | 32.1 | 25 | 3 | 1 | 2 | 3 | 1 | 9 | 17 | 52.9% | 4 | 7 | 57.1% | 3 | 5 | 60.0% | 14.0 |
| 2026-04-05 | ORL @ NOP | W | 34.1 | 27 | 6 | 4 | 1 | 1 | 2 | 8 | 19 | 42.1% | 3 | 8 | 37.5% | 8 | 11 | 72.7% | 8.0 |
| 2026-04-03 | ORL @ DAL | W | 33.4 | 27 | 7 | 5 | 3 | 0 | 1 | 8 | 13 | 61.5% | 3 | 5 | 60.0% | 8 | 9 | 88.9% | 27.0 |
| 2026-04-01 | ORL vs. ATL | L | 29.8 | 14 | 2 | 2 | 0 | 0 | 2 | 5 | 13 | 38.5% | 2 | 6 | 33.3% | 2 | 3 | 66.7% | -15.0 |
| 2026-03-31 | ORL vs. PHX | W | 37.3 | 21 | 6 | 5 | 1 | 1 | 5 | 6 | 16 | 37.5% | 2 | 6 | 33.3% | 7 | 8 | 87.5% | 5.0 |
| 2026-03-29 | ORL @ TOR | L | 26.5 | 17 | 3 | 2 | 0 | 0 | 3 | 5 | 10 | 50.0% | 2 | 4 | 50.0% | 5 | 6 | 83.3% | -25.0 |
| 2026-03-26 | ORL vs. SAC | W | 34.8 | 23 | 0 | 6 | 0 | 0 | 2 | 6 | 11 | 54.5% | 3 | 6 | 50.0% | 8 | 8 | 100.0% | 8.0 |
| 2026-03-24 | ORL @ CLE | L | 36.4 | 17 | 7 | 3 | 2 | 0 | 2 | 5 | 13 | 38.5% | 1 | 3 | 33.3% | 6 | 6 | 100.0% | -5.0 |
| 2026-03-23 | ORL vs. IND | L | 32.5 | 17 | 6 | 7 | 0 | 0 | 0 | 7 | 15 | 46.7% | 1 | 5 | 20.0% | 2 | 3 | 66.7% | -4.0 |
| 2026-03-21 | ORL vs. LAL | L | 38.1 | 12 | 4 | 5 | 3 | 1 | 5 | 4 | 14 | 28.6% | 1 | 6 | 16.7% | 3 | 3 | 100.0% | -10.0 |
| 2026-03-19 | ORL @ CHA | L | 25.7 | 24 | 7 | 2 | 1 | 0 | 2 | 8 | 15 | 53.3% | 3 | 5 | 60.0% | 5 | 5 | 100.0% | -21.0 |
| 2026-03-17 | ORL vs. OKC | L | 36.3 | 16 | 3 | 1 | 1 | 0 | 0 | 6 | 11 | 54.5% | 4 | 7 | 57.1% | 0 | 0 | 0.0% | -6.0 |
| 2026-03-16 | ORL @ ATL | L | 31.2 | 18 | 2 | 4 | 1 | 0 | 1 | 7 | 16 | 43.8% | 3 | 7 | 42.9% | 1 | 1 | 100.0% | -24.0 |
| 2026-03-14 | ORL @ MIA | W | 34.9 | 21 | 4 | 4 | 0 | 1 | 3 | 8 | 17 | 47.1% | 1 | 5 | 20.0% | 4 | 4 | 100.0% | 4.0 |
| 2026-03-12 | ORL vs. WAS | W | 42.1 | 22 | 1 | 6 | 3 | 0 | 1 | 7 | 14 | 50.0% | 2 | 5 | 40.0% | 6 | 6 | 100.0% | 14.0 |
| 2026-03-11 | ORL vs. CLE | W | 35.7 | 35 | 6 | 6 | 1 | 0 | 0 | 12 | 19 | 63.2% | 2 | 3 | 66.7% | 9 | 10 | 90.0% | 3.0 |
| 2026-03-08 | ORL @ MIL | W | 30.3 | 18 | 5 | 9 | 4 | 0 | 3 | 6 | 12 | 50.0% | 1 | 3 | 33.3% | 5 | 5 | 100.0% | 28.0 |
| 2026-03-07 | ORL @ MIN | W | 33.1 | 30 | 3 | 4 | 1 | 0 | 2 | 10 | 17 | 58.8% | 0 | 5 | 0.0% | 10 | 10 | 100.0% | 13.0 |
| 2026-03-05 | ORL vs. DAL | W | 37.5 | 14 | 8 | 3 | 0 | 0 | 1 | 5 | 13 | 38.5% | 1 | 3 | 33.3% | 3 | 3 | 100.0% | -8.0 |
| 2026-03-03 | ORL vs. WAS | W | 33.1 | 25 | 2 | 4 | 0 | 0 | 0 | 7 | 10 | 70.0% | 3 | 5 | 60.0% | 8 | 8 | 100.0% | 27.0 |
| 2026-03-01 | ORL vs. DET | L | 37.9 | 17 | 4 | 7 | 1 | 0 | 2 | 5 | 14 | 35.7% | 1 | 3 | 33.3% | 6 | 7 | 85.7% | -14.0 |
| 2026-02-26 | ORL vs. HOU | L | 37.7 | 30 | 6 | 4 | 2 | 0 | 1 | 12 | 19 | 63.2% | 6 | 10 | 60.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-02-24 | ORL @ LAL | W | 36.1 | 22 | 1 | 6 | 1 | 0 | 1 | 9 | 19 | 47.4% | 2 | 8 | 25.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-02-22 | ORL @ LAC | W | 32.0 | 36 | 5 | 1 | 2 | 0 | 1 | 13 | 19 | 68.4% | 4 | 6 | 66.7% | 6 | 10 | 60.0% | 12.0 |
| 2026-02-21 | ORL @ PHX | L | 39.6 | 34 | 4 | 3 | 2 | 1 | 2 | 12 | 18 | 66.7% | 5 | 9 | 55.6% | 5 | 5 | 100.0% | -7.0 |
| 2026-02-19 | ORL @ SAC | W | 32.0 | 17 | 4 | 2 | 2 | 1 | 0 | 6 | 9 | 66.7% | 3 | 5 | 60.0% | 2 | 3 | 66.7% | 11.0 |
| 2026-02-11 | ORL vs. MIL | L | 38.9 | 31 | 2 | 5 | 2 | 1 | 4 | 11 | 17 | 64.7% | 8 | 11 | 72.7% | 1 | 1 | 100.0% | -7.0 |
| 2026-02-09 | ORL vs. MIL | W | 30.9 | 25 | 3 | 1 | 0 | 0 | 2 | 8 | 11 | 72.7% | 2 | 5 | 40.0% | 7 | 7 | 100.0% | 9.0 |
| 2026-02-07 | ORL vs. UTA | W | 35.6 | 22 | 3 | 2 | 1 | 0 | 3 | 6 | 14 | 42.9% | 2 | 5 | 40.0% | 8 | 10 | 80.0% | 10.0 |
| 2026-02-05 | ORL vs. BKN | W | 31.8 | 23 | 3 | 4 | 4 | 0 | 2 | 7 | 14 | 50.0% | 1 | 7 | 14.3% | 8 | 9 | 88.9% | 20.0 |
| 2026-02-03 | ORL @ OKC | L | 21.5 | 7 | 2 | 2 | 1 | 2 | 2 | 3 | 7 | 42.9% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -11.0 |
| 2026-02-01 | ORL @ SAS | L | 37.2 | 25 | 4 | 4 | 1 | 0 | 2 | 10 | 17 | 58.8% | 1 | 2 | 50.0% | 4 | 4 | 100.0% | -10.0 |
| 2026-01-30 | ORL vs. TOR | W | 36.4 | 32 | 1 | 2 | 0 | 0 | 2 | 11 | 15 | 73.3% | 7 | 10 | 70.0% | 3 | 3 | 100.0% | 17.0 |
| 2026-01-28 | ORL @ MIA | W | 36.6 | 23 | 1 | 5 | 2 | 0 | 1 | 10 | 16 | 62.5% | 3 | 6 | 50.0% | 0 | 0 | 0.0% | -5.0 |
| 2026-01-26 | ORL @ CLE | L | 38.5 | 19 | 4 | 0 | 1 | 1 | 0 | 7 | 17 | 41.2% | 3 | 7 | 42.9% | 2 | 2 | 100.0% | -17.0 |
| 2026-01-24 | ORL vs. CLE | L | 38.4 | 20 | 4 | 3 | 2 | 0 | 3 | 7 | 14 | 50.0% | 2 | 6 | 33.3% | 4 | 4 | 100.0% | -8.0 |
| 2026-01-22 | ORL vs. CHA | L | 32.1 | 21 | 5 | 4 | 0 | 0 | 1 | 8 | 13 | 61.5% | 3 | 5 | 60.0% | 2 | 2 | 100.0% | -15.0 |
| 2026-01-18 | ORL @ MEM | L | 36.5 | 11 | 4 | 3 | 2 | 1 | 2 | 4 | 12 | 33.3% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -20.0 |
| 2026-01-15 | ORL @ MEM | W | 33.8 | 13 | 4 | 5 | 0 | 2 | 3 | 5 | 13 | 38.5% | 1 | 5 | 20.0% | 2 | 2 | 100.0% | 16.0 |
| 2026-01-11 | ORL vs. NOP | W | 35.3 | 27 | 5 | 4 | 2 | 0 | 3 | 9 | 18 | 50.0% | 1 | 4 | 25.0% | 8 | 8 | 100.0% | 17.0 |
| 2026-01-09 | ORL vs. PHI | L | 37.8 | 23 | 5 | 5 | 0 | 0 | 2 | 9 | 19 | 47.4% | 0 | 3 | 0.0% | 5 | 5 | 100.0% | -9.0 |
| 2026-01-07 | ORL @ BKN | W | 35.3 | 9 | 3 | 3 | 2 | 0 | 4 | 4 | 14 | 28.6% | 1 | 6 | 16.7% | 0 | 0 | 0.0% | -6.0 |
| 2026-01-06 | ORL @ WAS | L | 23.6 | 15 | 2 | 3 | 0 | 0 | 4 | 5 | 8 | 62.5% | 1 | 2 | 50.0% | 4 | 6 | 66.7% | -12.0 |
| 2026-01-04 | ORL vs. IND | W | 36.5 | 31 | 6 | 6 | 2 | 1 | 2 | 12 | 17 | 70.6% | 3 | 6 | 50.0% | 4 | 4 | 100.0% | 10.0 |
| 2026-01-02 | ORL @ CHI | L | 37.8 | 14 | 4 | 4 | 1 | 1 | 1 | 5 | 12 | 41.7% | 3 | 8 | 37.5% | 1 | 1 | 100.0% | 3.0 |
| 2025-12-31 | ORL @ IND | W | 33.4 | 18 | 7 | 6 | 0 | 0 | 2 | 7 | 17 | 41.2% | 1 | 4 | 25.0% | 3 | 3 | 100.0% | 2.0 |
| 2025-12-29 | ORL @ TOR | L | 29.9 | 18 | 6 | 3 | 0 | 1 | 0 | 6 | 18 | 33.3% | 1 | 4 | 25.0% | 5 | 5 | 100.0% | -6.0 |
| 2025-12-27 | ORL vs. DEN | W | 38.1 | 24 | 1 | 6 | 0 | 0 | 1 | 7 | 13 | 53.8% | 0 | 2 | 0.0% | 10 | 10 | 100.0% | 15.0 |
| 2025-12-26 | ORL vs. CHA | L | 32.7 | 15 | 10 | 4 | 0 | 1 | 4 | 7 | 19 | 36.8% | 0 | 6 | 0.0% | 1 | 2 | 50.0% | -6.0 |
| 2025-12-23 | ORL @ POR | W | 35.6 | 23 | 4 | 5 | 3 | 3 | 4 | 6 | 15 | 40.0% | 4 | 7 | 57.1% | 7 | 7 | 100.0% | 4.0 |
| 2025-12-22 | ORL @ GSW | L | 33.0 | 20 | 4 | 3 | 0 | 2 | 2 | 8 | 16 | 50.0% | 2 | 2 | 100.0% | 2 | 3 | 66.7% | -10.0 |
| 2025-12-20 | ORL @ UTA | W | 39.3 | 32 | 6 | 1 | 2 | 1 | 5 | 13 | 21 | 61.9% | 3 | 7 | 42.9% | 3 | 4 | 75.0% | 2.0 |
| 2025-12-18 | ORL @ DEN | L | 36.4 | 6 | 2 | 8 | 0 | 2 | 1 | 3 | 11 | 27.3% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | -15.0 |
| 2025-12-13 | ORL @ NYK | L | 37.5 | 18 | 6 | 7 | 1 | 0 | 3 | 7 | 17 | 41.2% | 2 | 4 | 50.0% | 2 | 2 | 100.0% | -4.0 |
| 2025-12-09 | ORL vs. MIA | W | 38.0 | 37 | 6 | 5 | 1 | 0 | 1 | 14 | 24 | 58.3% | 6 | 9 | 66.7% | 3 | 3 | 100.0% | 11.0 |
| 2025-12-07 | ORL @ NYK | L | 33.6 | 16 | 6 | 4 | 1 | 0 | 0 | 7 | 15 | 46.7% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | 0.0 |
| 2025-12-05 | ORL vs. MIA | W | 33.0 | 5 | 0 | 3 | 0 | 1 | 2 | 2 | 16 | 12.5% | 1 | 8 | 12.5% | 0 | 0 | 0.0% | 8.0 |
| 2025-12-03 | ORL vs. SAS | L | 37.6 | 14 | 3 | 6 | 0 | 0 | 1 | 6 | 15 | 40.0% | 2 | 3 | 66.7% | 0 | 0 | 0.0% | -3.0 |
| 2025-12-01 | ORL vs. CHI | W | 34.5 | 37 | 6 | 5 | 1 | 0 | 2 | 12 | 17 | 70.6% | 3 | 7 | 42.9% | 10 | 10 | 100.0% | 7.0 |
| 2025-11-28 | ORL @ DET | W | 39.3 | 37 | 8 | 2 | 1 | 2 | 2 | 13 | 25 | 52.0% | 0 | 5 | 0.0% | 11 | 12 | 91.7% | 0.0 |
| 2025-11-25 | ORL @ PHI | W | 28.6 | 15 | 2 | 6 | 2 | 0 | 2 | 6 | 15 | 40.0% | 1 | 5 | 20.0% | 2 | 2 | 100.0% | 44.0 |
| 2025-11-23 | ORL @ BOS | L | 28.7 | 18 | 4 | 5 | 0 | 0 | 1 | 6 | 13 | 46.2% | 1 | 2 | 50.0% | 5 | 6 | 83.3% | -9.0 |
| 2025-11-22 | ORL vs. NYK | W | 32.3 | 27 | 3 | 5 | 1 | 0 | 2 | 8 | 16 | 50.0% | 3 | 7 | 42.9% | 8 | 8 | 100.0% | 9.0 |
| 2025-11-20 | ORL vs. LAC | W | 30.8 | 15 | 7 | 5 | 1 | 0 | 2 | 5 | 15 | 33.3% | 3 | 6 | 50.0% | 2 | 2 | 100.0% | 13.0 |
| 2025-11-18 | ORL vs. GSW | W | 39.2 | 23 | 6 | 5 | 5 | 0 | 3 | 7 | 16 | 43.8% | 2 | 6 | 33.3% | 7 | 7 | 100.0% | -5.0 |
| 2025-11-16 | ORL @ HOU | L | 44.3 | 26 | 4 | 4 | 1 | 1 | 3 | 9 | 20 | 45.0% | 2 | 7 | 28.6% | 6 | 6 | 100.0% | -9.0 |
| 2025-11-14 | ORL vs. BKN | W | 39.9 | 19 | 5 | 2 | 0 | 0 | 3 | 7 | 18 | 38.9% | 3 | 7 | 42.9% | 2 | 2 | 100.0% | 16.0 |
| 2025-11-12 | ORL @ NYK | W | 33.9 | 22 | 6 | 8 | 0 | 0 | 3 | 7 | 15 | 46.7% | 3 | 6 | 50.0% | 5 | 5 | 100.0% | 13.0 |
| 2025-11-10 | ORL vs. POR | W | 33.2 | 22 | 3 | 7 | 0 | 0 | 3 | 9 | 19 | 47.4% | 1 | 6 | 16.7% | 3 | 3 | 100.0% | 1.0 |
| 2025-11-09 | ORL vs. BOS | L | 35.3 | 9 | 5 | 6 | 0 | 0 | 1 | 4 | 9 | 44.4% | 0 | 1 | 0.0% | 1 | 1 | 100.0% | 11.0 |
| 2025-11-07 | ORL vs. BOS | W | 36.1 | 22 | 6 | 7 | 1 | 2 | 1 | 8 | 15 | 53.3% | 2 | 5 | 40.0% | 4 | 5 | 80.0% | 25.0 |
| 2025-11-04 | ORL @ ATL | L | 22.6 | 9 | 3 | 2 | 1 | 0 | 3 | 2 | 6 | 33.3% | 2 | 4 | 50.0% | 3 | 5 | 60.0% | -13.0 |
| 2025-11-01 | ORL @ WAS | W | 19.9 | 5 | 0 | 5 | 2 | 0 | 0 | 2 | 6 | 33.3% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | 17.0 |
| 2025-10-30 | ORL @ CHA | W | 27.9 | 9 | 4 | 7 | 0 | 0 | 4 | 4 | 11 | 36.4% | 0 | 2 | 0.0% | 1 | 1 | 100.0% | 9.0 |
| 2025-10-29 | ORL @ DET | L | 30.8 | 12 | 5 | 2 | 0 | 0 | 1 | 4 | 15 | 26.7% | 1 | 4 | 25.0% | 3 | 3 | 100.0% | -21.0 |
| 2025-10-27 | ORL @ PHI | L | 34.4 | 24 | 3 | 1 | 0 | 0 | 0 | 10 | 17 | 58.8% | 2 | 7 | 28.6% | 2 | 2 | 100.0% | -14.0 |
| 2025-10-25 | ORL vs. CHI | L | 30.9 | 14 | 5 | 3 | 1 | 0 | 4 | 7 | 12 | 58.3% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -13.0 |
| 2025-10-24 | ORL vs. ATL | L | 33.4 | 15 | 7 | 5 | 0 | 0 | 3 | 5 | 14 | 35.7% | 1 | 7 | 14.3% | 4 | 5 | 80.0% | -7.0 |
| 2025-10-22 | ORL vs. MIA | W | 32.5 | 23 | 4 | 3 | 0 | 2 | 4 | 7 | 18 | 38.9% | 3 | 6 | 50.0% | 6 | 6 | 100.0% | -3.0 |